Resources

• Identify different types of interstitial lung disease (ILD)
• List key investigations to help identify the aetiology of ILD
• Summarise the treatment and management options available for patients affected by ILD

• Have a basic understanding and knowledge of how to interpret pulmonary lung function results, chest radiographs and CT chest imaging
• Be familiar with the national guidelines on interstitial lung disease

The following sessions are related:

• Interstitial Lung Disease and the Acute Medical Take (003-0010)
• Pathway to Diagnosing Interstitial Lung Disease (003-0011)
• Difficulties of Treating Interstitial Lung Disease (003-0012)
• Investigation and Management of Interstitial Lung Disease (003-0013)

Refer to the following links for more information:

• British Thoracic Society
• American Thoracic Society
• European Respiratory Society

Refer to the following text for additional information:

• National Institute for Health and Clinical Excellence. Clinical guideline 163. Idiopathic pulmonary fibrosis: The diagnosis and management of suspected idiopathic pulmonary fibrosis. 2013; London: NICE. View website

The following sources were referenced in this session:

1. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011;183(5):573-581.
2. Nunes H, Brillet PY, Valeyre D et al. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007;28(1):102-120.
3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357(21):2153-2165.
4. Bradley B, Branley HM, Egan JJ et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63(5):v1-v58.
5. Raghu G, Collard HR, Egan JJ et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
6. Wells AU, Behr J, Costabel U, Cottin V, Poletti V. Triple therapy in idiopathic pulmonary fibrosis: an alarming press release. Eur Respir J 2012;39(4):805-806.
7. National Institute for Health and Clinical Excellence. Idiopathic pulmonary fibrosis - pirfenidone (TA282). Pirfenidone for treating idiopathic pulmonary fibrosis. 2013; London: NICE. View website
8. National Institute for Health and Clinical Excellence. Clinical guideline 163. Idiopathic pulmonary fibrosis: The diagnosis and management of suspected idiopathic pulmonary fibrosis. 2013; London: NICE. View website
9. Churg A, Muller NL, Wright JL. Respiratory bronchiolitis/interstitial lung disease: fibrosis, pulmonary function, and evolving concepts. Arch Pathol Lab Med 2010;134(1):27-32.
10. Davies G, Wells AU, du Bois RM. Respiratory bronchiolitis associated with interstitial lung disease and desquamative interstitial pneumonia. Clin Chest Med 2004;25(4):717-726.
11. Cordier JF. Cryptogenic organizing pneumonia. Eur Respir J 2006;28(2):422-446.